Relation of Polymorphisms in Five Genes to Long-Term Aortocoronary Saphenous Vein Graft Patency

American Journal of Cardiology

Volumn 99, Issue 8, 2007, Pages 1087-1089

  Ellis, Stephen G ^a   Chen, Michael S ^a   Jia, Gang ^a   Luke, May ^b   Cassano, June ^a   Lytle, Bruce ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CELERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; HLA DP ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VASCULOTROPIN RECEPTOR 2; VITRONECTIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; FEMALE; GENETIC POLYMORPHISM; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

AGE FACTORS; ANTICHOLESTEREMIC AGENTS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; COMPLEMENT C3B; COMPLEMENT C4B-BINDING PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DP ANTIGENS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SAPHENOUS VEIN; SEX FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR PATENCY; VITRONECTIN;

EID: 34147129854     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.060     Document Type: Article

References (22)

1. Loop F.D., Lytle B.W., Cosgrove D.M., Goormastic S.M., Williams G.W., Golding L.A., Gill C.C., Taylor P.C., and Sheldon W.C. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 314 (1986) 1-6
2. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 suppl (2006) e85-e151
3. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T., Kern K.B., Seithi G., Sharma G.V.R.K., Khuri S., et al. Long-term graft patency (3 years) after coronary artery surgery: effects of aspirin: results of a VA Cooperative Study. Circulation 89 (1994) 1138-1143
4. Gavaghan T.P., Gebski V., and Baron D.W. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery: a placebo-controlled, randomized study. Circulation 83 (1991) 1526-1533
5. Domanski M.J., Borkowf C.B., Campeau L., Knatterud G.L., White C., Hoogwerf B., Rosenberg Y., and Geller N.L. Prognostic factors for atherosclerosis progression in saphenous vein grafts. J Am Coll Cardiol 36 (2000) 1877-1883
6. Zotz R.B., Klein M., Dauben H.P., Moser C., Gams E., and Scharf R.E. Prospective analysis after coronary-artery bypass grafting; platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thrombosis Haemost 83 (2000) 404-407
7. Moor E., Silveira A., van't Hooft F., Tornvall P., Blomback M., Wiman B., Ryden L., and Hamsten A. Coagulation factor V (Arg506→Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. Thrombosis Haemost 80 (1998) 220-224
8. Mihai V., Podgoreanu, and Schwinn D.A. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. J Am Coll Cardiol 46 (2005) 1965-1977
9. Ortlepp J.R., Janssens U., Bleckmann F., Lauscher J., Merkelbach-Bruse S., Hanrath P., and Hoffmann R. A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron Artery Dis 12 (2001) 493-497
10. Agah R., Ellis S.G., Chase S., Henderson M., Mlady L., Murugesan G., Tubbs R., Marchant K., Warshawsky I., Rouse C., et al. Creation of a large-scale genetic data bank for cardiovascular association studies. Am Heart J 150 (2005) 500-506
11. Shiffman D., Ellis S.G., Rowland C.M., Malloy M.J., Luke M.M., Iakoubova O.A., Pullinger C.R., Cassano J., Aouizerat B.E., Fenwick R.G., et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77 (2005) 596-605
12. Li Y., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Lau K., Catanese J., et al. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 366 (2004) 268-271
13. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57 (1995) 1289-1300
14. Centers for Disease Control and Prevention. The 29th Report from the Health, United States Series. Available at: www.ncbi.nlm.nih.gov/entrez/query.
15. Fujita Y., Yoshizumi M., Izawa Y., Ali N., Ohnishi H., Kanematsu Y., Ishizawa K., Tsuchiya K., and Tamaki T. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation. Endocrinology 147 (2006) 1377-1385
16. Kariyazono H., Ohno T., Khajoee V., Ihara K., Kusuhara K., Kinukawa N., Mizuno Y., and Hara T. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56 (2004) 953-959
17. Nikitina-Zake L., Ghaderi M., Park Y., Babu S., Eisenbarth G., and Sanjeevi C.B. MCIA gene polymorphism in HBDI multiplex families. Ann NY Acad Sci 1037 (2004) 150-156
18. Torn C., Gupta M., Sanjeevi C.B., Aberg A., Frid A., and Landin-Olsson M. Different HL-DR-DQ and MHC class I chain-related gene a (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population. Hum Immunol 65 (2004) 1443-1450
19. Chen M., Jia G., Luke M.M., Liu D.M., Topol E.J., Lytle B.W., and Ellis S.G. Genomic association of graft failure of the left internal thoracic artery for myocardial revascularization. J Am Coll Cardiol 47 (2006) 4 165A
20. Rahman S., Patel Y., Murray J., Patel K.V., Sumathipala R., Sobel M., and Wijelath E.S. Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signaling pathway in endothelial cells. BMC Cell Biol 17 (2005) 6-8
21. Podor T.J., Campbell S., Chindemi P., Foulon D.M., Farrell D.H., Walton P.D., Weitz J.I., and Peterson C.B. Incorporation of vitronectin into fibrin clots. Evidence for a binding intereaction between vitronectin and gamma A/gamma' fibrinogen. J Biol Chem 277 (2002) 7520-7528
22. Ekmekei H., Sonmez H., Ekmekei O.B., Ozturk Z., Domanic N., and Kokoglu E. Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. J Thromb Thrombolysis 14 (2002) 221-225